Inovio Pharmaceuticals, Inc. Accounts Payable for the year ending December 31, 2024: USD 6.44 M

Inovio Pharmaceuticals, Inc. Accounts Payable is USD 6.44 M for the year ending December 31, 2024, a 38.60% change year over year. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.
  • Inovio Pharmaceuticals, Inc. Accounts Payable for the year ending December 31, 2023 was USD 4.65 M, a -77.95% change year over year.
  • Inovio Pharmaceuticals, Inc. Accounts Payable for the year ending December 31, 2022 was USD 21.08 M, a -24.63% change year over year.
  • Inovio Pharmaceuticals, Inc. Accounts Payable for the year ending December 31, 2021 was USD 27.97 M, a 1,804.87% change year over year.
  • Inovio Pharmaceuticals, Inc. Accounts Payable for the year ending December 31, 2020 was USD 1.47 M, a -80.80% change year over year.
Key Data
Date Accounts Payable Short-Term Debt Long-Term Debt Total Liabilities